Protocols
1 protocol(s) meet the specified criteria
Drug: Niraparib
Protocol No.TitleStatus
3000-PN162-01-001Phase 1/2 Clinical Study of Niraparib in Combination with Pembrolizumab in Patients with Advanced or Metastatic Triple-Negative Breast Cancer and in Patients with Recurrent Ovarian CancerOpen